The short version of pentadecapeptide fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-11-09. Anything still debated is marked as such rather than presented as settled.
BPC-157 is a synthetic peptide of fifteen amino acids, written as GEPPPGKPADDAGLV, whose sequence matches part of a larger protein identified in human gastric juice. That parent protein was described in stomach-secretion research, and the fifteen-residue fragment was named body protection compound, which gives the peptide its common label. Material used in experiments is produced by solid-phase peptide synthesis rather than extracted from tissue. The reported molecular weight is about 1419 daltons, and the chain contains several proline residues, a feature that appears in discussions of its resistance to enzymatic breakdown.
Most published findings come from rodent models, where the peptide has been examined in wound-healing, gastrointestinal-lesion, tendon, and vascular-injury preparations. A smaller number of early human studies have been reported, chiefly in inflammatory bowel conditions, but the public record is short and has not led to marketing approval in the United States or the European Union. Reviewers therefore classify the compound as investigational, and whether animal results carry over to people remains an open question rather than a settled one.
Dry powder is generally stored at low temperature, with minus twenty degrees Celsius or colder advised for extended retention. Reconstituted solutions are less stable than the solid form and are normally kept cold and shielded from repeated freeze-thaw cycles. Light exposure is avoided because some peptides degrade under ultraviolet radiation. The exact rate of degradation depends on concentration, pH, and the presence of salts, so a single shelf life does not apply to every preparation. Reported stability figures should be read as indicative of typical handling rather than as universal constants.
Confirmation of identity and purity relies on standard peptide analysis techniques. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities and serves as the most common purity assay. Mass spectrometry, often coupled to that chromatography step, provides an accurate molecular mass that can be matched against the expected value. Amino acid analysis or sequencing can be added for further confirmation. Because short peptides can be produced by different synthetic routes, laboratories usually report both a chromatographic purity percentage and a mass confirmation rather than a single figure.
BPC-157 is commonly supplied as a lyophilized powder, a freeze-dried solid that is reconstituted before use in laboratory work. As a short peptide, it dissolves readily in water and in aqueous buffer solutions, and stock solutions are typically prepared in water or a mild buffer. The chain contains several proline and acidic residues, which influence how it behaves in solution. Because the solid can take up moisture, weighing and handling are usually performed under low-humidity conditions. Its solubility class is described as freely soluble in water rather than requiring an organic solvent.
| Property | Value | Notes |
|---|---|---|
| Origin | Fragment of a protein found in human gastric juice | Sequence corresponds to a fifteen-residue portion of the parent protein |
| Sequence | GEPPPGKPADDAGLV | Single linear chain, fifteen amino acids |
| Reported molecular weight | About 1419 daltons | Value quoted consistently in supplier and review literature |
| Regulatory status | Not an approved human medicine in the US or EU | Handled and sold as a research chemical |
| Sports status | Listed as prohibited | Falls under non-approved-substance categories in anti-doping codes |
Common synonyms in catalogs include pentadecapeptide BPC 157, BPC157, and the full sequence name. A CAS registry number in the 137525-51-0 range is frequently listed, though the assignment should be verified against the supplier certificate of analysis. The name itself is not a pharmacopoeial designation, and there is no standardized international nonproprietary name. Distinguishing genuine material from related fragments generally requires mass spectrometry, since several truncated sequences share similar chromatographic behavior.
BPC-157 is a synthetic pentadecapeptide whose sequence is commonly given as Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It is described in the literature as a fragment of a larger protein found in human gastric juice, referred to as body protection compound. The peptide was first characterized in the early 1990s by a research group in Zagreb, Croatia. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
Supplied material is typically a lyophilized white to off-white powder. The peptide is freely soluble in water and in common aqueous buffers, which allows it to be handled as a stock solution. Because the sequence contains no cysteine, disulfide cross-linking is not a route of degradation. The absence of aromatic residues means ultraviolet absorbance at 280 nm is minimal, so quantification usually relies on peptide bond absorbance near 214 nm or on amino acid analysis.
Proposed mechanisms in the literature involve the nitric oxide system, vascular endothelial growth factor signaling, and epidermal growth factor receptor pathways. Some studies report changes in blood vessel formation or in inflammatory mediators, while others describe interactions with nervous tissue. Much of this evidence rests on molecular markers in cultured cells or animal models. Whether the same pathways operate the same way in humans has not been established. Authors therefore tend to describe mechanisms as hypothetical rather than settled.
Direct human evidence is scarce. One trial in ulcerative colitis delivered the compound by enema and produced limited publicly reported results without a clear benefit. The compound is not an approved medicine in most jurisdictions. In many markets it is sold as a research chemical; in others it falls under prescription or controlled categories. Regulators have not confirmed any claimed medical use, and product labels rarely undergo premarket review.
BPC-157 is a synthetic pentadecapeptide with the sequence GEPPPGKPADDAGLV, corresponding to a partial fragment of a larger protein detected in human gastric juice. The name derives from the parent protein designation BPC, an abbreviation of body protection compound, with 157 acting as a fraction or batch identifier used by the original investigators. Its molecular weight is approximately 1419 daltons, and the chain contains no unusual residues or disulfide bridges. In the literature it is described as a short, water-soluble fragment rather than a complete natural protein.
Most early work on this peptide originated in the 1990s from a research group in Zagreb, Croatia, relying on animal models and cell cultures. Reported observations included effects on gastrointestinal lesion healing, tendon fibroblast migration, and blood vessel formation under controlled laboratory conditions. These findings come predominantly from rodent studies and in vitro assays rather than from human trials. Controlled human data remain limited, and the degree to which animal results translate to human physiology is an open question rather than a settled fact.
BPC-157 is a synthetic peptide composed of fifteen amino acids. Its sequence corresponds to part of a protein found in human gastric juice, which is the origin of the "body protection compound" label. In laboratory work the material is treated as a defined research chemical rather than a finished product. Published research has centered on animal models, and the peptide is not an approved medicine in most countries.
The peptide was first described in the early 1990s by a group studying gastric secretions and tissue repair. Its fifteen-residue chain is usually written as GEPPPGKPADDAGLV in single-letter code. The free peptide has the formula C62H98N16O22 and a theoretical mass near 1419.5 daltons. These identifiers are established chemical facts that can be checked against standard peptide databases. There is no ambiguity about the primary structure.
Most published findings come from rodent experiments using induced injury or surgical models. Human reports remain scarce and are largely observational, which limits how much can be stated with confidence. Questions about absorption, distribution, metabolism, and clearance in people are still open. Dose translation between species is likewise unresolved. Researchers tend to read the animal literature as a starting point rather than a settled account.
=== Japan === Between 1992 and 1997, Japan's Ministry of International Trade and Industry sponsored a "New Hydrogen Energy (NHE)" program of US$20 million to research cold fusion. Announcing the end of the program in 1997, the director and one-time proponent of cold fusion research Hideo Ikegami stated "We couldn't achieve what was first claimed in terms of cold fusion. (...) We can't find any reason to propose more money for the coming year or for the future." In 1999 the Japan C-F Research Society was established to promote the independent research into cold fusion that continued in Japan. The society holds annual meetings. Perhaps the most famous Japanese cold fusion researcher was Yoshiaki Arata, from Osaka University, who claimed in a demonstration to produce excess heat when deuterium gas was introduced into a cell containing a mixture of palladium and zirconium oxide, a claim supported by fellow Japanese researcher Akira Kitamura of Kobe University and Michael McKubre at SRI.
Brazil also fields the R3 Emergency Operation Ration (Portuguese: Ração Operacional de Emergência – R3), a 12-hour ration to be used in situations where cooked foods cannot be provided for all meals. The R3 ration is similar to the R2 and uses the same components, but contains less food. The bag is printed with the emblem of the Brazilian Army, "Emergency Ration R3 (12 hours)" (Portuguese: Ração de Emergência R3 (12 Horas)) and Menu information. Inside are 3 thin plastic bags: 2 meal bags and 1 accessory packet.
has no real roots. While all of the above inequalities are true because a, b, and c must follow the basic triangle inequality that the longest side is less than half the perimeter, the following relations hold for all positive a, b, and c:
Wetsuits are economical and used where the water temperature is not too low - more than about 65 °F (18 °C), the diver will not be spending too long in the water, and the water is reasonably clean. Dry suits are better thermal protection than most wetsuits, and isolate the diver from the environment more effectively than other exposure suits. When diving in contaminated water, a drysuit with integral boots, sealed dry gloves and a helmet sealed directly to the suit provides the best environmental isolation. The suit material must be selected to be compatible with the expected contaminants. Thermal undersuits can be matched to the expected water temperature. Hot water suits provide active warming which is particularly suitable for use with helium based breathing gases. Heated water is provided from the surface through a hose in the umbilical, and water flow can be adjusted to suit the diver's needs. Heated water continuously flows into the suit and is distributed by perforated internal tubes down the front and back of the torso and along the limbs.
Sources: en.wikipedia.org
== Catabolism and excretion == Steroids are primarily oxidized by cytochrome P450 oxidase enzymes, such as CYP3A4. These reactions introduce oxygen into the steroid ring, allowing the cholesterol to be broken up by other enzymes into bile acids. These acids can then be eliminated by secretion from the liver in bile. The expression of the oxidase gene can be upregulated by the steroid sensor PXR when there is a high blood concentration of steroids. Steroid hormones, lacking the side chain of cholesterol and bile acids, are typically hydroxylated at various ring positions or oxidized at the 17 position, conjugated with sulfate or glucuronic acid and excreted in the urine.
Neo fends off hundreds of these Smiths and escapes. Later, he, Morpheus and Trinity steal the Keymaker from his keeper, the Merovingian. During this time, Neo stays behind to fight off the Merovingian's men and becomes separated from the others, being trapped in the Merovingian's mansion five hundred miles away in the mountains. He flies off to help them and only just arrives in time to save Morpheus and the Keymaker from two agents crashing two trucks together. The Keymaker explains that two power stations elsewhere in the Matrix must be disabled in a short time window to successfully disable the security system of a building where the door to the Source will appear, allowing Neo to reach it. This task is accomplished, but the Keymaker is killed, a hovercraft is destroyed and Trinity is jeopardized by the agents of the Matrix, illustrating a vision that Neo has seen earlier in his dreams. Entering the door, Neo finds himself confronted by the Architect, a program which created and designed the Matrix and also ensures its constant stability. The Architect presents Neo with a radically different explanation of his origins and purpose, claiming that Neo is actually the sixth "One". He goes on to say that Zion has been destroyed by the machines five times before; faced with the dilemma of allowing humanity to be destroyed or allowing the machines' preferred status quo to be reconstructed, Neo's five predecessors have helped reload or restart the Matrix, before being allowed to rebuild Zion with a handful of freed humans.
In 1676, Anton van Leeuwenhoek observed bacteria and other microorganisms, using a single-lens microscope of his own design. In 1796, Edward Jenner developed a method using cowpox to successfully immunize a child against smallpox. The same principles are used for developing vaccines today. Following on from this, in 1857 Louis Pasteur also designed vaccines against several diseases such as anthrax, fowl cholera and rabies as well as pasteurization for food preservation. In 1867 Joseph Lister is considered to be the father of antiseptic surgery. By sterilizing the instruments with diluted carbolic acid and using it to clean wounds, post-operative infections were reduced, making surgery safer for patients. In the years between 1876 and 1884 Robert Koch provided much insight into infectious diseases. He was one of the first scientists to focus on the isolation of bacteria in pure culture. This gave rise to the germ theory, a certain microorganism being responsible for a certain disease. He developed a series of criteria around this that have become known as the Koch's postulates. A major milestone in medical microbiology is the Gram stain. In 1884 Hans Christian Gram developed the method of staining bacteria to make them more visible and differentiated under a microscope. This technique is widely used today. In 1910 Paul Ehrlich tested multiple combinations of arsenic based chemicals on infected rabbits with syphilis. Ehrlich then found that arsphenamine was found effective against syphilis spirochetes. The arsphenamines was then made available in 1910, known as Salvarsan.
==== United States ==== Under federal United States law, phenazepam is not currently classified as a controlled substance, as the Federal Analog Act only provides for automatic assumed classification of chemicals "substantially similar" to existing Schedule I or Schedule II drugs, whereas all controlled benzodiazepines under the Controlled Substances Act are classified as Schedule IV. Although phenazepam is currently not controlled, sale for human use remains illegal in the United States. Suppliers attempt to circumvent this regulation by placing a "Not for human use" disclaimer on the product's label. Individual states in the United States often ban these analog drugs by name as they appear. Since 2012, Louisiana has classified phenazepam as a controlled dangerous substance. This ban affects several products, some of which were sold at retail stores under the guise of air freshener or similar, containing phenazepam yet claiming not to be for human use. This legislation was introduced after one such product, branded as "Zannie" and marketed as an air freshener rapidly gained publicity as the subject of numerous media reports, attracting the attention of officials. The ensuing investigation effort, led by Senator Fred Mills and Louisiana Poison Center Director Mark Ryan, positively identified the active ingredient of "Zannie" as phenazepam. According to Ryan, chemical analysis identified the active ingredient as "100 percent phenazepam".
=== Combinations === Analgesics are frequently used in combination, such as the paracetamol and codeine preparations found in many non-prescription pain relievers. They can also be found in combination with vasoconstrictor drugs such as pseudoephedrine for sinus-related preparations, or with antihistamine drugs for people with allergies. While the use of paracetamol, aspirin, ibuprofen, naproxen, and other NSAIDs concurrently with weak to mid-range opioids (up to about the hydrocodone level) has been said to show beneficial synergistic effects by combating pain at multiple sites of action, several combination analgesic products have been shown to have few efficacy benefits when compared to similar doses of their individual components. Moreover, these combination analgesics can often result in significant adverse events, including accidental overdoses, most often due to confusion that arises from the multiple (and often non-acting) components of these combinations.
Sources: en.wikipedia.org
residents determined to be at the greatest risk of exposure to counterfeit products through personal prescription drug importation, are aged greater than 45 years, reside in the south or west regions of the U.S., are of Hispanic ethnicity, college educated, poor or near poor poverty status, lacking U.S. citizenship, traveling to developing countries, lacking health insurance, managing high family out-of-pocket medical costs, having trouble finding a healthcare provider, self-reporting fair or poor health status, filling a prescription on the Internet, and using online chat groups to learn about health. Recent evidence suggests that provision of health insurance coverage may effectively reduce importation and the subsequent risk of exposure to counterfeit medicines, especially among particular subpopulations.
These species feature elements from groups I, II, III, IV, V, VI, VII, 0 (excluding hydrogen) of the periodic table. Due to their often similar reactivity, the elements in group 3 (Sc, Y, and La) and group 12 (Zn, Cd, and Hg) are also generally included, and the lanthanides and actinides are sometimes included as well. Main group compounds have been known since the beginnings of chemistry, e.g., elemental sulfur and the distillable white phosphorus. Experiments on oxygen, O2, by Lavoisier and Priestley not only identified an important diatomic gas, but opened the way for describing compounds and reactions according to stoichiometric ratios. The discovery of a practical synthesis of ammonia using iron catalysts by Carl Bosch and Fritz Haber in the early 1900s deeply impacted mankind, demonstrating the significance of inorganic chemical synthesis. Typical main group compounds are SiO2, SnCl4, and N2O. Many main group compounds can also be classed as "organometallic", as they contain organic groups, e.g., B(CH3)3. Main group compounds also occur in nature, e.g., phosphate in DNA, and therefore may be classed as bioinorganic. Conversely, organic compounds lacking (many) hydrogen ligands can be classed as "inorganic", such as the fullerenes, buckytubes and binary carbon oxides.
At the Battle of Carabobo on 24 June, the Gran Colombian forces decisively defeated the royalist forces, assuring control of Venezuela save for Puerto Cabello and guaranteeing Venezuelan independence. Bolívar could now concentrate on Gran Colombia's claims to southern New Granada and Quito.
After Independence, Pakistan vigorously pursued bilateral relations with other Muslim countries. The Ali brothers sought to project Pakistan as the natural leader of the Islamic world, partly due to its significant manpower and military strength. Khaliquzzaman, a prominent Muslim League leader, declared Pakistan's ambition to unite all Muslim countries into Islamistan, a pan-Islamic entity. These developments, alongside Pakistan's creation, didn't receive approval from the United States, with British Prime Minister Clement Attlee expressing a hope for India and Pakistan to reunite. However, due to a nationalist awakening in the Arab world at that time, there was little interest in Pakistan's Pan-Islamic aspirations. Some Arab countries perceived the 'Islamistan' project as Pakistan's bid to dominate other Muslim states. Pakistan's founder, Muhammad Ali Jinnah, consistently advocated for the Palestinian cause, shaping Pakistan's foreign policy to support Palestinian rights within the broader framework of Muslim solidarity. During the 1967 Arab-Israel war, Pakistan supported the Arab states and played a key role in securing Iran's backing for the Arab cause both within the U.N. and beyond. Pakistan's relations with Iran have been strained by sectarian tensions, with both Iran and Saudi Arabia using Pakistan as a battleground for their proxy sectarian war. Since the early days of the Iran–Iraq war, President Zia-ul-Haq played an important mediatory role, with Pakistan actively engaging in efforts to end the conflict.
Sources: en.wikipedia.org
It is not approved for human use in the United States or the European Union. Clinical material has been studied in a small number of early trials, mainly for inflammatory bowel conditions, and the compound remains investigational. Regulators treat marketed products as unapproved rather than as authorized drugs.
The peptide was named after a protein fraction found in human gastric juice, and the shorter form was called body protection compound. That phrase was shortened to the abbreviation BPC. The number 157 refers to a laboratory designation used in the original isolation work.
Its sequence corresponds to a segment of a protein present in gastric secretions, but the material supplied for research is made synthetically. No commercial product is purified from human or animal tissue. The synthetic route is used because it gives a defined chain length and a reproducible sequence.
The lyophilized powder is normally kept at minus twenty degrees Celsius or colder. Solutions are held at refrigerator temperature or below and protected from light. Repeated freezing and thawing is avoided because it can promote aggregation or loss of activity.